CURIS INC 8-K

What Happened

• Curis, Inc. announced in an 8-K filed Feb. 9, 2026 that on February 3, 2026 it received written notice from Nasdaq stating the company has regained compliance with Nasdaq Listing Rule 5550(b)(2) (the MVLS Rule) and is in full compliance with the terms imposed by the Nasdaq Hearings Panel. The filing was signed by Diantha Duvall, Chief Financial Officer.

Key Details

• Notice date from Nasdaq: February 3, 2026; 8-K filed: February 9, 2026.
• Regained compliance specifically with Nasdaq Listing Rule 5550(b)(2) (MVLS Rule).
• Per Listing Rule 5815(d)(4)(A), Curis will be subject to a discretionary Panel monitor for one year.
• If Curis again falls out of compliance during that year, Nasdaq Staff will issue a Delist Determination Letter without allowing a new compliance plan or cure period, and Curis may request a hearing with a Hearings Panel.

Why It Matters

• Regaining compliance means Curis’s shares remain listed on Nasdaq for now, avoiding immediate delisting.
• The one-year discretionary monitor increases regulatory scrutiny: any future noncompliance during that period could trigger an expedited delisting process without the usual opportunity for a cure, which could affect liquidity, investor confidence, and access to capital.
• The filing also contains standard forward-looking statement cautions and refers investors to the company’s 2024 Form 10-K risk factors.